Reeli Reinu, PA
Physician Assistant · Maitland, FLNPI 1609884253
Payments from drug & device makers
Across 1,427 payments — averaging $299.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$353K
- Janssen Scientific Affairs, LLC$60K
- AbbVie$2K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$2K
- Dermavant Sciences, Inc.$2K
- Incyte Corporation$1K
- plus $7K from 25 others
What the payments were for
- Consulting fees$37,3209%
- Speaking & faculty fees$290,45568%
- Travel & lodging$72,40217%
- Food & beverage$26,6326%
- Education$4890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 776 | $353,287 |
| Janssen Scientific Affairs, LLC | 85 | $59,854 |
| AbbVie | 163 | $2,382 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $1,863 |
| Dermavant Sciences, Inc. | 38 | $1,700 |
| Incyte Corporation | 15 | $1,475 |
| Regeneron Healthcare Solutions, Inc. | 30 | $895 |
| Novartis | 66 | $789 |
| Lilly USA, LLC | 39 | $687 |
| UCB, Inc. | 24 | $637 |
| Sanofi | 28 | $612 |
| LEO Pharma Inc. | 21 | $513 |
| Sun Pharmaceutical Industries Inc. | 16 | $409 |
| Arcutis Biotherapeutics, Inc. | 8 | $392 |
| Galderma Laboratories, L.p. | 37 | $360 |
| E.r. Squibb & Sons, L.L.C. | 17 | $326 |
| Amgen | 11 | $276 |
| Almirall LLC | 8 | $220 |
| Organon | 10 | $109 |
| Pfizer | 5 | $102 |
| Organogenesis Inc. | 3 | $93 |
| Boehringer Ingelheim | 3 | $62 |
| Biofrontera Inc. | 3 | $61 |
| Genentech USA, Inc. | 2 | $38 |
| Mayne Pharma Commercial LLC | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Strata Skin Sciences, Inc. | 2 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $23 |
| Journey Medical Corporation | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $21 |
| Botanix SB Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$427,298 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TremfyaGuselkumab | 16 | $218,243 |
| Dupixent PenDupilumab | 19 | $86,510 |
| Clobetasol Propionate | 99 | $4,011 |
| Mometasone Furoate | 106 | $1,416 |
| Fluorouracil | 19 | $1,369 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 19 | $1,231 |
| Tretinoin | 17 | $1,198 |
| Ketoconazole | 74 | $1,047 |
| Metronidazole | 16 | $977 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 70 | $964 |
| Triamcinolone Acetonide | 101 | $926 |
| Betamethasone Dipropionate | 20 | $777 |
| Doxycycline Hyclate | 38 | $731 |
| Ciclopirox | 16 | $441 |
| Clindamycin Phosphate | 14 | $367 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $353,287 | $218,24316 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Maitland
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.